Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2022. Start Trial.
Date Value
December 31, 2025 373.70M
December 31, 2024 262.15M
Date Value
December 31, 2023 80.68M
December 31, 2022 42.46M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Ligand Pharmaceuticals, Inc. 733.52M
Xeris Biopharma Holdings, Inc. 111.04M
ANI Pharmaceuticals, Inc. 294.75M
Corcept Therapeutics, Inc. 372.15M
Veru, Inc. 18.32M